Experiment 440392
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | SUGITA,K: FURUKAWA,T: TSUCHIDA,M: OKAWA,Y: NAKAZAWA,S: AKATSUKA,J: OHIRA,M: NISHIMURA,K:. (1993). HIGH FREQUENCY OF ETOPOSIDE (VP-16)-RELATED SECONDARY LEUKEMIA IN CHILDREN WITH NON-HODGKIN'S LYMPHOMA.. 15(1) |
| Amount utilized | |
| Compound isolated | |
| Disease | 5/38 PATIENTS WITH NON-HODGKINS LYMPHOMA OR KI-1 ANTIGEN-POSITIVE LYMPHOMA WHO WERE TREATED WITH COMPOUND AND BEHENOYLCYTOSINE ARABINOSIDE DEVELOPED ACUTE MYELOID LEUKEMIA 21 MONTHS (MEDIAN) AFTER INITIATION OF CHEMOTHERAPY. CUMULATIVE DOSE OF COMPOUND GIVEN. |
| Dose amount | 5.6 GM |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | KG |
| Dose expression | DOSE |